Penguin Solutions, Inc. ("Penguin Solutions," "we," "us," or the "Company") today reported financial results for the first quarter of fiscal 2025. First Quarter Fiscal 2025 Highlights Net sales of ...
LUMRYZ, is an extended-release sodium oxybate medication approved by the FDA on May 1, 2023, as the first and only once-at-bedtime treatment for cataplexy or excessive daytime sleepiness (EDS) in ...
Investors absorbed a report that President-elect Donald Trump is considering declaring a national economic emergency to pave the way for proposed tariffs.